Amanote Research
Register
Sign In
Acute Double Blind Trial of a New Anti-Anginal Drug: Molsidomine
European Journal of Clinical Pharmacology
- Germany
doi 10.1007/bf00609879
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Pharmacology
Date
January 1, 1979
Authors
Unknown
Publisher
Springer Nature
Related search
Therapeutic Monitoring of the Anti-Anginal Drug Perhexiline Maleate
Annals of Clinical Biochemistry
Medicine
Clinical Biochemistry
A Double-Blind, Randomized Trial of PY108-068 in Acute Ischemic Cerebral Infarction
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Penotrane in Blepharitis. A Double-Blind Controlled Trial.
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Effect of Fasudil, a Protein Kinase Inhibitor, on Acute Cerebral Infarction-Results of a Double Blind Trial-
Nosotchu
Dopaminergic Agonist Nomifensine Compared With Amitriptyline: A Double- Blind Clinical Trial in Acute Primary Depressions.
British Journal of Clinical Pharmacology
Pharmacology
Effect of Zinc Supplementation in Children With Acute Diarrhea: Randomized Double Blind Controlled Trial
Gastroenterology Research
A 6 Week Randomized Double-Blind Placebo-Controlled Trial of Ziprasidone for the Acute Depressive Mixed State
PLoS ONE
Multidisciplinary
Aripiprazol Versus Quetiapine in Treatment of Non-Affective Acute Psychosis: A Double-Blind, Randomized - Controlled Clinical Trial
American Journal of Psychiatry and Neuroscience
Effectiveness of Anti-Osteoporotic Treatment After Successful Parathyroidectomy for Primary Hyperparathyroidism: A Randomized, Double-Blind, Placebo-Controlled Trial
Langenbeck's Archives of Surgery
Surgery
